Detalhe da pesquisa
1.
Structure and drug resistance of the Plasmodium falciparum transporter PfCRT.
Nature
; 576(7786): 315-320, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776516
2.
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance.
PLoS Pathog
; 18(2): e1010278, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130315
3.
Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials.
J Infect Dis
; 226(11): 2021-2029, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082431
4.
tRNA modification reprogramming contributes to artemisinin resistance in Plasmodium falciparum.
Nat Microbiol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632343
5.
Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology.
mBio
; 15(1): e0183223, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059639
6.
Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment.
Trends Parasitol
; 38(9): 711-718, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864072
7.
Turning the tide: targeting PfCRT to combat drug-resistant P. falciparum?
Nat Rev Microbiol
; 18(5): 261-262, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300249